147 related articles for article (PubMed ID: 2523870)
1. Acute and chronic effects of ramipril and captopril in congestive heart failure.
de Graeff PA; Kingma JH; Viersma JW; Wesseling H; Lie KI
Int J Cardiol; 1989 Apr; 23(1):59-67. PubMed ID: 2523870
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
de Graeff PA; Kingma JH; Dunselman PH; Wesseling H; Lie KI
Am J Cardiol; 1987 Apr; 59(10):164D-170D. PubMed ID: 3034026
[TBL] [Abstract][Full Text] [Related]
3. Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
Manthey J; Osterziel KJ; Röhrig N; Dietz R; Hackenthal E; Schmidt-Gayk H; Kübler W
Am J Cardiol; 1987 Apr; 59(10):171D-175D. PubMed ID: 2953224
[TBL] [Abstract][Full Text] [Related]
4. Global and regional hemodynamic effects of ramipril in congestive heart failure.
Crozier IG; Ikram H; Nicholls MG; Jans S
J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
[TBL] [Abstract][Full Text] [Related]
5. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
Todd PA; Benfield P
Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure.
Crozier IG; Ikram H; Nicholls MG; Jans S
Am J Cardiol; 1987 Apr; 59(10):155D-163D. PubMed ID: 3034025
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of the new angiotensin converting enzyme inhibitor ramipril on hemodynamics and carotid sinus baroreflex activity in congestive heart failure.
Vogt A; Unterberg C; Kreuzer H
Am J Cardiol; 1987 Apr; 59(10):149D-154D. PubMed ID: 3034024
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
11. Steady-state kinetics of ramipril in renal failure.
Schunkert H; Kindler J; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Sieberth HG
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S52-4. PubMed ID: 2474104
[TBL] [Abstract][Full Text] [Related]
12. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
[TBL] [Abstract][Full Text] [Related]
14. Ramipril: a review of the new ACE inhibitor.
Mills TP
J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of ramipril.
Ball SG; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
[TBL] [Abstract][Full Text] [Related]
16. Ramipril: review of pharmacology.
Becker RA; Schölkens B
Am J Cardiol; 1987 Apr; 59(10):3D-11D. PubMed ID: 3034030
[TBL] [Abstract][Full Text] [Related]
17. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
Bauer B; Lorenz H; Zahlten R
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
[TBL] [Abstract][Full Text] [Related]
18. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
Witte PU; Walter U
Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
[TBL] [Abstract][Full Text] [Related]
19. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
20. Comparison of captopril and enalapril in patients with severe chronic heart failure.
Packer M; Lee WH; Yushak M; Medina N
N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
